Zobrazeno 61 - 70
of 173
pro vyhledávání: '"Jan Westerink"'
Autor:
Andra C. Dumitru, Eric Mignolet, Mauriane Maja, Jan Westerink, Richard van Wijk, Giulio G. Muccioli, Minke A.E. Rab, Laura G.M. Daenen, David Alsteens, Anne-Sophie Cloos, Juliette Vanderroost, Donatienne Tyteca, Romano Terrasi, Yvan Larondelle, Patrick Van Der Smissen, Amaury Stommen
Publikováno v:
Frontiers in Physiology, Vol 12 (2021)
Frontiers in Physiology
Frontiers in Physiology, Vol. 12, no. 2, p. 638027 [1-22] (2021)
Frontiers in Physiology
Frontiers in Physiology, Vol. 12, no. 2, p. 638027 [1-22] (2021)
Familial hypobetalipoproteinemia is a metabolic disorder mainly caused by mutations in the apolipoprotein B gene. In its homozygous form it can lead without treatment to severe ophthalmological and neurological manifestations. In contrast, the hetero
Autor:
Jostein Gleditsch, Lucia J.M. Kroft, Eli Westerlund, Charlotte E.A. Dronkers, Mathilde Nijkeuter, Anders von Heijne, Herman M.A. Hofstee, Stan Kolman, Lisette F. van Dam, Gargi Gautam, Waleed Ghanima, Frederikus A. Klok, Marcel A. van de Ree, Robin E. Westerbeek, Cornelis J. van Rooden, Jan Westerink, Wilbert B. van den Hout, Marcel M. C. Hovens, Menno V. Huisman, Albert T. A. Mairuhu
Publikováno v:
Blood Advances, 5(5), 1369-1378. AMER SOC HEMATOLOGY
Blood Adv
Blood Adv
The diagnostic workup of recurrent ipsilateral deep vein thrombosis (DVT) using compression ultrasonography (CUS) can be complicated by persistent intravascular abnormalities after a previous DVT. We showed that magnetic resonance direct thrombus ima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ff7a9e1183d00c4856f4b20238d6b42
https://hdl.handle.net/1887/3229728
https://hdl.handle.net/1887/3229728
Autor:
L. J. Kappelle, Gert J. de Borst, Leonie M. M. Fassaert, Raechel J. Toorop, L. Jaap Kappelle, Bart-Jeroen Petri, Wilton A. van Klei, Eline S. van Hattum, Jan Westerink
Publikováno v:
Annals of vascular surgery. 77
Background Hemodynamic disturbances cause half of the perioperative strokes following carotid endarterectomy (CEA). Guidelines strongly recommend strict pre- and postoperative blood pressure (BP) monitoring in CEA patients, but do not provide firm pr
Publikováno v:
Diabetic Medicine, 36(9), 1125. Wiley-Blackwell
Diabetic Medicine
Diabetic Medicine
Aim To quantify the risk of different non‐invasive arterial stiffness measurements with macrovascular disease and all‐cause mortality in high‐risk people with Type 2 diabetes. Methods We conducted a prospective cohort study of 1910 people with
Publikováno v:
Research and Practice in Thrombosis and Haemostasis
Background Clinicians lack substantiated guidance on when vitamin K antagonist (VKA) treatment should be interrupted preoperatively, especially with regard to phenprocoumon, with its long half‐life of 5.5 days. Objective To evaluate the efficacy of
Autor:
Gert J. de Borst, Frans L. Moll, Evelien E. de Vries, Jan Westerink, Anne Hoskam, Hester M. den Ruijter, A. Huibers
Publikováno v:
European Journal of Vascular and Endovascular Surgery, 56(3), 322. W.B. Saunders Ltd
Introduction Cerebral hyperperfusion syndrome (CHS) is a preventable cause of stroke after carotid endarterectomy (CEA). There are currently no pooled data available on the incidence of CHS after carotid artery stenting (CAS). The aim of this review
Autor:
Angela C. Shore, Henri E J H Stoffers, Mark A. Espeland, Mary M. McDermott, Shao Yuan Chuang, Carlos Lahoz, Kate Boddy, John Goddard, Richard J McManus, Robyn L. McClelland, Sarah F. Moore, Marie Dahl, Luigi Ferrucci, Lyne Cloutier, Rafel Ramos Blanes, Nigel Reed, Jan Westerink, Fiona C Warren, Ji-Guang Wang, James F. White, Andrew T. Hattersley, Rod S Taylor, Christopher E Clark, John Campbell, Michael H. Criqui, Maëlenn Guerchet, Malcolm Turner, Sinead T. J. McDonagh, Raimund Erbel, Gunnar Engström, Victor Aboyans, Jackie F. Price, Maria Teresa Alzamora
Publikováno v:
Hypertension, 77(2), 650-661. LIPPINCOTT WILLIAMS & WILKINS
Clark, C E, Warren, F C, Boddy, K, McDonagh, S T J, Moore, S F, Goddard, J, Reed, N, Turner, M, Alzamora, M T, Ramos Blanes, R, Chuang, S-Y, Criqui, M, Dahl, M, Engström, G, Erbel, R, Espeland, M, Ferrucci, L, Guerchet, M, Hattersley, A, Lahoz, C, McClelland, R L, McDermott, M M, Price, J, Stoffers, H E, Wang, J-G, Westerink, J, White, J, Cloutier, L, Taylor, R S, Shore, A C, McManus, R J, Aboyans, V & Campbell, J L 2021, ' Associations Between Systolic Interarm Differences in Blood Pressure and Cardiovascular Disease Outcomes and Mortality : Individual Participant Data Meta-Analysis, Development and Validation of a Prognostic Algorithm: The INTERPRESS-IPD Collaboration ', Hypertension, vol. 77, no. 2, pp. HYPERTENSIONAHA12015997 . https://doi.org/10.1161/HYPERTENSIONAHA.120.15997
Hypertension (Dallas, Tex. : 1979)
Hypertension (Dallas, Tex. : 1979), vol 77, iss 2
Clark, C E, Warren, F C, Boddy, K, McDonagh, S T J, Moore, S F, Goddard, J, Reed, N, Turner, M, Alzamora, M T, Ramos Blanes, R, Chuang, S-Y, Criqui, M, Dahl, M, Engström, G, Erbel, R, Espeland, M, Ferrucci, L, Guerchet, M, Hattersley, A, Lahoz, C, McClelland, R L, McDermott, M M, Price, J, Stoffers, H E, Wang, J-G, Westerink, J, White, J, Cloutier, L, Taylor, R S, Shore, A C, McManus, R J, Aboyans, V & Campbell, J L 2021, ' Associations Between Systolic Interarm Differences in Blood Pressure and Cardiovascular Disease Outcomes and Mortality : Individual Participant Data Meta-Analysis, Development and Validation of a Prognostic Algorithm: The INTERPRESS-IPD Collaboration ', Hypertension (Dallas, Tex. : 1979), vol. 77, no. 2, pp. 650–661 . https://doi.org/10.1161/HYPERTENSIONAHA.120.15997
Clark, C E, Warren, F C, Boddy, K, McDonagh, S T J, Moore, S F, Goddard, J, Reed, N, Turner, M, Alzamora, M T, Ramos Blanes, R, Chuang, S-Y, Criqui, M, Dahl, M, Engström, G, Erbel, R, Espeland, M, Ferrucci, L, Guerchet, M, Hattersley, A, Lahoz, C, McClelland, R L, McDermott, M M, Price, J, Stoffers, H E, Wang, J-G, Westerink, J, White, J, Cloutier, L, Taylor, R S, Shore, A C, McManus, R J, Aboyans, V & Campbell, J L 2021, ' Associations Between Systolic Interarm Differences in Blood Pressure and Cardiovascular Disease Outcomes and Mortality : Individual Participant Data Meta-Analysis, Development and Validation of a Prognostic Algorithm: The INTERPRESS-IPD Collaboration ', Hypertension, vol. 77, no. 2, pp. HYPERTENSIONAHA12015997 . https://doi.org/10.1161/HYPERTENSIONAHA.120.15997
Hypertension (Dallas, Tex. : 1979)
Hypertension (Dallas, Tex. : 1979), vol 77, iss 2
Clark, C E, Warren, F C, Boddy, K, McDonagh, S T J, Moore, S F, Goddard, J, Reed, N, Turner, M, Alzamora, M T, Ramos Blanes, R, Chuang, S-Y, Criqui, M, Dahl, M, Engström, G, Erbel, R, Espeland, M, Ferrucci, L, Guerchet, M, Hattersley, A, Lahoz, C, McClelland, R L, McDermott, M M, Price, J, Stoffers, H E, Wang, J-G, Westerink, J, White, J, Cloutier, L, Taylor, R S, Shore, A C, McManus, R J, Aboyans, V & Campbell, J L 2021, ' Associations Between Systolic Interarm Differences in Blood Pressure and Cardiovascular Disease Outcomes and Mortality : Individual Participant Data Meta-Analysis, Development and Validation of a Prognostic Algorithm: The INTERPRESS-IPD Collaboration ', Hypertension (Dallas, Tex. : 1979), vol. 77, no. 2, pp. 650–661 . https://doi.org/10.1161/HYPERTENSIONAHA.120.15997
Supplemental Digital Content is available in the text.
Systolic interarm differences in blood pressure have been associated with all-cause mortality and cardiovascular disease. We undertook individual participant data meta-analyses to (1) quanti
Systolic interarm differences in blood pressure have been associated with all-cause mortality and cardiovascular disease. We undertook individual participant data meta-analyses to (1) quanti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f9f32fc50a5614c83c6c15a4f7f20dd
https://cris.maastrichtuniversity.nl/en/publications/e590d18a-b287-47b3-a4b5-e6203ed7c7be
https://cris.maastrichtuniversity.nl/en/publications/e590d18a-b287-47b3-a4b5-e6203ed7c7be
Autor:
J A N Dorresteijn, Jan Westerink, Frank L.J. Visseren, M. L. Bots, Arend Mosterd, Steven H J Hageman, Folkert W. Asselbergs
Publikováno v:
European Heart Journal. 41
Background Identification of patients who benefit most from further risk factor lowering may help to effectively reduce residual risk of cardiovascular disease (CVD) in patients with symptomatic atherosclerotic disease. Using the previously published
Autor:
Jan Westerink, Nadia E Bonekamp, Frank L.J. Visseren, Wilko Spiering, Hendrik M. Nathoe, L. J. Kappelle, G.J. de Borst
Publikováno v:
European Heart Journal. 41
Background Randomised controlled trials (RCTs) are the main source of evidence for clinical treatment guidelines. However, there are concerns that strict eligibility criteria for participant selection may limit applicability of trial results to real-
Autor:
Nancy R. Cook, Folkert W. Asselbergs, Joachim G.J.V. Aerts, Paul M. Ridker, Frank L.J. Visseren, Y. van der Graaf, C.C. Van 'T Klooster, Jan Westerink
Publikováno v:
European Heart Journal. 41
Background As treatment for cardiovascular disease (CVD) has improved substantially over the last decades, more patients survive acute CVD manifestations and are at risk for developing cancer as well as recurrent CVD. Due to similar risk factors, inc